Eli Lilly & Co. said Thursday that its Type 2 diabetes drug Mounjaro and its weight-loss and diabetes drug Zepbound drove a ...
As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...
Hosted on MSN6mon
Why the weight-loss drug boom is just the beginningFuelled by blockbuster marvels like Ozempic and Mounjaro, which were developed ... including Wegovy and Zepound. Pharma giants Novo Nordisk and Eli Lilly are leading the charge with these game ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results